CSI Market
Sign In | Register

Vyne Therapeutics Inc (VYNE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VYNE Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Vyne Therapeutics Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent22.93
Marketable Securities, Current SH0.00
Cash & Short-term Investments22.00
Prepaid Expense And Other Assets Current0.60
Total Current Assets23.53
Equipment/Property/Plant Net0.12
Other Assets, Noncurrent0.00
Prepaid Expense And Other Assets Noncurrent-
Operating Lease Right Of Use Asset-
Total Assets23.60
Liabilities
Accounts Payable, Trade, Current0.61
Accrued Liabilities, Current0.82
Other Liabilities, Current0.11
Total Current Liabilities1.54
Total Long-term Debt0.00
Operating Lease Liability Current-
Total Liabilities1.54
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock786.31
Retained Earnings / Accumulated Deficit-764.25
Other Equity0.00
Common Stockholder's Equity22.06
Total Stockholder's Equity22.06
Liabilities & Stockholder's Equity23.60
4 historic quarters locked

Sign in to unlock the full Vyne Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Yarrow Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001566044-26-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.